![]() Have you missed me in your in-box? Even if you didn’t notice or were relieved to have one less email to delete, I’d like to explain that the unplanned sabbatical over the last few months was due to family matters that required my full attention. I’m happy to report that all is well and, for better or worse, I’m back at the keyboard. Whether or not you are pleased by this news, I could not let the year come to an end without presenting my traditional top ten quiz of the stupidest new drug names of 2024. And 2024, with all its ups and downs, produced a bumper crop of entirely unpronounceable labels for new pharmaceuticals. Choosing merely ten out of the 60 novel drugs approved by the FDA in the past 12 months was like trying to eat only one potato chip. I promise you; I am not making these up! ALYFTREK
HYMPAVZI
YORVIPATH
LAZCLUZE
LEQSELVI
XOLREMDI
UNLOXCYT
ZIIHERA
RAPIBLYK
REZDIFFRA
And honorable mention goes to Exblifep, Zelsuvmi, Tevimbra, and Nemluvio, all of which are causing my spellcheck a nervous breakdown. And in case you have any interest left at all, here are the uses for the drugs: Alyftrek: cystic fibrosis; Hympavzi: hemophilia; Yorvipath: hypoparathyroidism; Lazcluze: lung cancer; Leqselvi: alopecia; Xolremdi: WHIM syndrome; Unloxcyt: carcinoma; Ziihera: biliary tract cancer; Rapiblyk: tachycardia; Rezdiffra: liver From my family to yours, I wish you a happy and healthy New Year. Hopefully, I will continue to invade your inbox once a month in 2025. I thank you for your continued indulgence. I couldn’t possibly have this much fun without you! |
About the AuthorSusan is the author of two award-winning collections of humorous personal essays: “How Old Am I in Dog Years?” and “How to Complain When There’s Nothing to Complain About.” Check out her Author Page HERE. Archives
April 2025
Categories |